In a report released today, Peter Lawson from Barclays maintained a Buy rating on Kura Oncology (KURA – Research Report), with a price target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback